LIGAND PHARMACEUTICALS INC's ticker is and the CUSIP is 53220KAF5. A total of 49 filers reported holding LIGAND PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $1,873,000 | -83.8% | 1,912,000 | -83.5% | 0.00% | -50.0% |
| Q4 2021 | $11,582,000 | +247.8% | 11,554,000 | +248.9% | 0.00% | +100.0% |
| Q3 2021 | $3,330,000 | +282.8% | 3,312,000 | +276.4% | 0.00% | – |
| Q2 2021 | $870,000 | -63.5% | 880,000 | -61.7% | 0.00% | -100.0% |
| Q1 2021 | $2,381,000 | +939.7% | 2,299,000 | +853.9% | 0.00% | – |
| Q4 2020 | $229,000 | -86.9% | 241,000 | -87.5% | 0.00% | -100.0% |
| Q3 2020 | $1,750,000 | +1.9% | 1,925,000 | -2.6% | 0.00% | 0.0% |
| Q2 2020 | $1,718,000 | +25.1% | 1,976,000 | +24.7% | 0.00% | 0.0% |
| Q4 2019 | $1,373,000 | +140.0% | 1,584,000 | +131.2% | 0.00% | – |
| Q3 2019 | $572,000 | -12.3% | 685,000 | -9.4% | 0.00% | – |
| Q2 2019 | $652,000 | – | 756,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| STEELHEAD PARTNERS LLC | 70,062,000 | $61,167,000 | 7.51% |
| SYMPHONY ASSET MANAGEMENT LLC | 18,000,000 | $15,668,000 | 5.06% |
| Context Capital Management, LLC | 6,350,000 | $5,569,000 | 2.17% |
| CANYON CAPITAL ADVISORS LLC | 60,000,000 | $52,680,000 | 1.76% |
| Opti Capital Management, LP | 8,500 | $7,400,000 | 1.26% |
| III Capital Management | 5,000,000 | $4,365,000 | 1.08% |
| FALCON POINT CAPITAL, LLC | 250,000 | $219,000 | 1.07% |
| Venator Capital Management Ltd. | 1,500,000 | $1,308,000 | 0.86% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 30,500,000 | $26,576,000 | 0.62% |
| DAVIDSON KEMPNER CAPITAL MANAGEMENT LP | 22,500,000 | $19,733,000 | 0.48% |